AlphaCrest Capital Management’s Sysco SYY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-74,274
Closed -$5.25M 1015
2022
Q3
$5.25M Buy
74,274
+68,119
+1,107% +$5.67M 0.32% 19
2022
Q2
$521K Sell
6,155
-11,287
-65% -$945K 0.03% 942
2022
Q1
$1.42M Buy
17,442
+7,179
+70% +$580K 0.08% 386
2021
Q4
$806K Sell
10,263
-14,602
-59% -$1.12M 0.03% 897
2021
Q3
$1.95M Sell
24,865
-10,714
-30% -$817K 0.1% 318
2021
Q2
$2.77M Sell
35,579
-36,172
-50% -$2.92M 0.12% 246
2021
Q1
$5.65M Buy
71,751
+27,679
+63% +$2.15M 0.31% 51
2020
Q4
$3.27M Buy
44,072
+39,750
+920% +$2.73M 0.27% 77
2020
Q3
$269K Sell
4,322
-39,338
-90% -$2.29M 0.03% 915
2020
Q2
$2.39M Buy
43,660
+17,254
+65% +$907K 0.4% 30
2020
Q1
$1.21M Buy
26,406
+4,223
+19% +$292K 0.15% 200
2019
Q4
$1.9M Sell
22,183
-2,559
-10% -$207K 0.16% 126
2019
Q3
$1.97M Sell
24,742
-10,495
-30% -$770K 0.12% 240
2019
Q2
$2.49M Sell
35,237
-14,311
-29% -$1.02M 0.22% 104
2019
Q1
$3.31M Buy
49,548
+41,533
+518% +$2.7M 0.5% 18
2018
Q4
$502K Buy
+8,015
New +$540K 0.15% 241

Other funds holding SYY

AlphaCrest Capital Management's SYY Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Sysco (SYY) in Q4 2022, closing a stake of 74,274 shares — an estimated $5.25M sold.

AlphaCrest Capital Management first reported a position in SYY in Q4 2018 and held it in 16 quarters. The position peaked at $5.65M in Q1 2021. 1,442 funds tracked by Wall St. Rank hold SYY as of Q4 2022.

  • AlphaCrest Capital Management reported no remaining Sysco position as of Q4 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 74,274 Sysco shares in Q4 2022, an estimated $5.25M.
  • AlphaCrest Capital Management first reported a position in Sysco in Q4 2018 and held it in 16 quarters.
  • AlphaCrest Capital Management's Sysco position peaked at $5.65M in Q1 2021.
  • 1,442 funds tracked by Wall St. Rank held Sysco as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.